Streetbeat News

SNES

SenesTech, Inc.

https://www.senestech.com

Industry

Chemicals - Specialty

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Open

2.43

Mkt cap

2.3M

Volume

231K

High

2.43

P/E Ratio

0.02

52-wk high

9.80

Low

2.12

Div yield

N/A

52-wk low

1.90

StoneCo Ltd. (NASDAQ:STNE) shares increased by over 6% in pre-market trading following the company's third-quarter earnings report, which surpassed market expectations. StoneCo reported adjusted earnings of 27 cents per share against the estimated 22 cents, with sales of $643.35 million exceeding the forecast of $610.17 million. Other stocks also showed pre-market movements, with notable gainers including SenesTech, Inc. (NASDAQ:SNES), Collective Audience, Inc. (NASDAQ:CAUD), and Tivic Health Systems, Inc. (NASDAQ:TIVC), among others. Conversely, several stocks were trading lower, such as Monopar Therapeutics (NASDAQ:MNPR), eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), and Motus GI Holdings, Inc. (NASDAQ:MOTS).

Portfolio Pulse from Lisa Levin

November 13, 2023 | 1:24 pm

In Monday's pre-market session, several healthcare stocks showed significant movement. Tivic Health Systems (TIVC) saw a 116.8% increase, while SenesTech (SNES) rose by 65.78%. ZyVersa Therapeutics (ZVSA) and Cingulate (CING) also experienced gains. On the downside, TC BioPharm (TCBP) dropped by 89.2%, Aclaris Therapeutics (ACRS) fell by 85.6%, and Verve Therapeutics (VERV) declined by 31.53%. Other stocks such as TRACON Pharma (TCON), Monopar Therapeutics (MNPR), and Singular Genomics Systems (OMIC) also saw decreases. Earnings reports seem to be a driving factor for many of these movements.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 1:06 pm

In Friday's after-market session, several healthcare stocks experienced significant movements. Comera Life Sciences (CMRA), SenesTech (SNES), Aravive (ARAV), China SXT Pharmaceuticals (SXTC), Co-Diagnostics (CODX), and Oncternal Therapeutics (ONCT) saw gains following their Q3 earnings reports. Conversely, XTL Biopharmaceuticals (XTLB), NeuroMetrix (NURO), TRACON Pharma (TCON), Jaguar Health (JAGX), Intelligent Bio Solutions (INBS), and Sunshine Biopharma (SBFM) experienced declines. The movements were attributed to recent earnings reports and trading volumes.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 9:31 pm

SenesTech shares have declined following the announcement of lower than expected revenue for Q3, indicating a negative market reaction to the company's financial performance.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:45 pm

In Friday's pre-market session, several healthcare stocks saw significant movement. TRACON Pharma, Motus GI Hldgs, Assure Hldgs, Intelligent Bio Solutions, INVO Bioscience, and AVITA Medical were the gainers, with increases ranging from 20.44% to 106.2%. On the other hand, Fortress Biotech, Aptevo Therapeutics, Biolase, SenesTech, Illumina, and NanoVibronix were the losers, with decreases ranging from 11.11% to 29.3%.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 1:07 pm

SenesTech (NASDAQ:SNES) reported its Q3 earnings, beating estimated earnings by 44.71% with an EPS of $-0.47 versus an estimate of $-0.85. Revenue was up $110 thousand from the same period last year. Last quarter, the company beat on EPS by $0.08, which was followed by a 0.0% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:50 pm

SenesTech reported Q3 2023 GAAP EPS of $(0.47), beating the estimate of $(0.85) by 44.71%. However, the company's sales of $360.00K missed the estimate of $570.00K by 36.84%. Despite the miss, this represents a 44.00% increase in sales compared to the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 09, 2023 | 9:48 pm

The article lists the stocks that gained and lost the most in Thursday's mid-day session. Among the gainers were Intelligent Bio Solutions Inc., Astra Space, Inc., and Tempest Therapeutics, Inc., which saw significant increases due to positive quarterly results and acquisition proposals. Among the losers were Enviva Inc., ContraFect Corporation, and Atara Biotherapeutics, Inc., which saw significant decreases due to poor quarterly results and disappointing clinical trial outcomes.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 6:13 pm

SenesTech (NASDAQ:SNES) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.85. The company's stock performance has been generally negative over the last 52-week period, with shares down 90.26%. The company's past performance has shown that earnings beats or misses do not necessarily affect the stock price, but the guidance does.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 6:02 pm

Several healthcare stocks experienced significant movement in Wednesday's after-market session. Notable gainers included Atreca (BCEL), SenesTech (SNES), Akili (AKLI), Cue Health (HLTH), Candel Therapeutics (CADL), and Evelo Biosciences (EVLO). On the other hand, Nemaura Medical (NMRD), PaxMedica (PXMD), Bio-Path Hldgs (BPTH), NeuroOne Medical Tech (NMTC), Tiziana Life Sciences (TLSA), and Akanda (AKAN) saw their shares decrease.

Portfolio Pulse from Benzinga Insights

October 18, 2023 | 9:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.